Triggered Activation and Release of Liposomal Prodrugs and Drugs in Cancer Tissue by Secretory Phospholipase A2

E-ISSN： 1875-5704|2|4|353-362

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.2, Iss.4, 2005-10, pp. : 353-362

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Concise Update on the Relevance of Secretory Phospholipase A2 Group IIA and its Inhibitors with Cancer

Medicinal Chemistry, Vol. 13, Iss. 7, 2017-10 ,pp. : 606-615

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Secretory Phospholipase A2 Group IIA

Current Medicinal Chemistry, Vol. 12, Iss. 25, 2005-12 ,pp. : 3011-3026

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancer

By Hare Jennifer I. Moase Elaine H. Allen Theresa M.

Journal of Drug Targeting, Vol. 21, Iss. 1, 2013-01 ,pp. : 87-96

Informa Healthcare

Access to resources Recommend Favorite

Tissue Transport of Anti-cancer Drugs

Current Pharmaceutical Design, Vol. 8, Iss. 22, 2002-10 ,pp. : 1987-1993

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis of Azetidin-2-One Derivatives as Inhibitor of Secretory Phospholipase A2 with Anti-Inflammatory Activity

Letters in Drug Design & Discovery, Vol. 2, Iss. 4, 2005-06 ,pp. : 307-310

Bentham Science Publishers

Access to resources Recommend Favorite